Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11044278rdf:typepubmed:Citationlld:pubmed
pubmed-article:11044278lifeskim:mentionsumls-concept:C0019169lld:lifeskim
pubmed-article:11044278lifeskim:mentionsumls-concept:C0037140lld:lifeskim
pubmed-article:11044278lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:11044278lifeskim:mentionsumls-concept:C0337910lld:lifeskim
pubmed-article:11044278pubmed:issue9lld:pubmed
pubmed-article:11044278pubmed:dateCreated2000-10-26lld:pubmed
pubmed-article:11044278pubmed:abstractTextWe studied hepatitis B virus (HBV) transmission among 7416 Thai children from 148 schools in Kamphaeng Phet province, a rural part of northern Thailand. Their age ranged from 2 to 16 years (median 9 years). Between May 1991 and June 1992, 61 of 2593 (2.4%) in the cohort of susceptible children acquired anti-HBc immunoglobulin. Forty-seven of the 148 schools had children who acquired anti-HBc. School seroconversion rates to anti-HBc varied from 0% to 23%. There was no correlation between percent of carriers in schools and percent of anti-HBc acquisition. Of the 61 children who acquired anti-HBc, eight (13%) became HBsAg carriers but only two were symptomatic, for a clinical to subclinical infection ration of 1 : 30. One of the two symptomatic children became an HBsAg carrier. Three (38%) of the eight who were persistently antigenemic developed antibody to hepatitis B virus e antigen. Males were 2.5 times (95% CI 1.4-4.3) more likely to acquire anti-HBc than females. Risk factors for acquisition of HBc in Thailand over a 9-month period were examined in a subset of 2412 susceptible children and later in a case-control study of 22 children who acquired anti-HBc and 59 age and sex-matched controls. Risks for acquiring anti-HBc were male gender and a history of bleeding gums. In comparing this study to an earlier pilot study among 9848 children from the same area in Thailand, the yearly antibody acquisition rate to anti-HBc among Thai children dropped from 5.7% in 1989 to 2.4% in 1992. A random sample of children in the pilot study showed that 16% were HBsAg positive and 27% had anti-HBc at the beginning of the study. 34% had markers for either anti-HBc or HBsAg. 12% were repeatedly positive for HBsAg a year later.lld:pubmed
pubmed-article:11044278pubmed:languageenglld:pubmed
pubmed-article:11044278pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11044278pubmed:citationSubsetIMlld:pubmed
pubmed-article:11044278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11044278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11044278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11044278pubmed:statusMEDLINElld:pubmed
pubmed-article:11044278pubmed:monthSeplld:pubmed
pubmed-article:11044278pubmed:issn1360-2276lld:pubmed
pubmed-article:11044278pubmed:authorpubmed-author:SnitbhanRRlld:pubmed
pubmed-article:11044278pubmed:authorpubmed-author:VaughnD WDWlld:pubmed
pubmed-article:11044278pubmed:authorpubmed-author:InnisB LBLlld:pubmed
pubmed-article:11044278pubmed:authorpubmed-author:KozikC ACAlld:pubmed
pubmed-article:11044278pubmed:issnTypePrintlld:pubmed
pubmed-article:11044278pubmed:volume5lld:pubmed
pubmed-article:11044278pubmed:ownerNLMlld:pubmed
pubmed-article:11044278pubmed:authorsCompleteYlld:pubmed
pubmed-article:11044278pubmed:pagination633-9lld:pubmed
pubmed-article:11044278pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:meshHeadingpubmed-meshheading:11044278...lld:pubmed
pubmed-article:11044278pubmed:year2000lld:pubmed
pubmed-article:11044278pubmed:articleTitleHepatitis B virus infection in Thai children.lld:pubmed
pubmed-article:11044278pubmed:affiliationDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.lld:pubmed
pubmed-article:11044278pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11044278pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:11044278pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:11044278pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11044278lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11044278lld:pubmed